LGE negative n = 21 | LGE positive n = 16 | p | |
---|---|---|---|
Cardiovascular risk factors | |||
Diabetes | 3 (14%) | 4 (25%) | 0.41 |
Hypertension | 8 (38%) | 5 (31%) | 0.67 |
Smokinga | 8 (38%) | 5 (31%) | 0.98 |
Hyperlipidemia | 2 (10%) | 4 (25%) | 0.21 |
Family history of CVD | 6 (29%) | 5 (31%) | 0.86 |
Obesity (BMI ≥ 30 kg/m2) | 6 (29%) | 3 (19%) | 0.49 |
Symptoms (multiple possible) | |||
Angina | 2 (10%) | 4 (25%) | 0.21 |
Dyspnea | 8 (38%) | 8 (50%) | 0.55 |
Palpitations | 2 (10%) | 2 (13%) | 0.72 |
Syncope | - | 1 (6%) | 0.25 |
ECG abnormality | 5 (24%) | 6 (38%) | 0.37 |
Years since diagnosis | |||
< 1 | 8 (38%) | 4 (25%) | 0.57 |
1–4 | 5 (24%) | 6 (38%) | 0.63 |
5–9 | 7 (33%) | 4 (25%) | 0.67 |
≥ 10 | 1 (5%) | 2 (13%) | 0.39 |
Disease Activity | |||
BVAS | 4 (1–19) | 6 (2.5–12.5) | 0.91 |
Hematocrit | 0.39 (0.32–0.41) | 0.41 (0.38–0.44) | 0.10 |
Medication | |||
Beta-blockers | 5 (24%) | 4 (25%) | 0.93 |
ARB | 10 (48%) | 4 (25%) | 0.16 |
ASA | - | 5 (31%) | |
CCB | 6 (29%) | 2 (13%) | 0.24 |
Statins | 1 (5%) | 2 (13%) | 0.37 |
Diuretics | 4 (19%) | 4 (25%) | 0.66 |
Steroids | 21 (100%) | 16 (100%) | 0.16 |
NSAID | 1 (5%) | - | |
Antibodies | 2 (10%) | - | |
Cyclophosphamide | 11 (52%) | 6 (38%) | 0.67 |
Azathioprine | 1 (5%) | 3 (19%) | 0.18 |
Methotrexate | 2 (10%) | 3 (19%) | 0.42 |